jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Oct. 01, 2018

Sept. 10, 2019

jRCT2080224071

K-755 Phase 1 study

K-755 Phase 1 study

Kowa Company, Ltd.

ctrdinfo@kowa.co.jp

Kowa Company, Ltd.

ctrdinfo@kowa.co.jp

completed

Sept. 24, 2018

78

Interventional

DBT

other

1

healthy males

subjects who having a history of drug allergy

20age old over
35age old under

Male

healthy males

investigational material(s)
Generic name etc : K-755
INN of investigational material : -
Therapeutic category code : --- Other
Dosage and Administration for Investigational material : Oral dose

control material(s)
Generic name etc : Placebo
INN of investigational material : -
Therapeutic category code : --- Other
Dosage and Administration for Investigational material : Oral dose

safety
adverse events, adverse drug reactions
incidence rate

safety
clinical tests
change from before administration

Kowa Co., Ltd.
-
-
-
Medical Corporation Heishinkai OPHAC Hospital
4-1-29 Miyahara, Yodogawa-ku, Osaka-shi, Osaka

+81-6-6395-9000

sumiko.kawamoto@heishinkai.com
approved

Sept. 21, 2018

JapicCTI-184132
Japan

History of Changes

No Publication date
4 Sept. 10, 2019 (this page) Changes
3 Dec. 17, 2018 Detail Changes
2 Oct. 01, 2018 Detail Changes
1 Oct. 01, 2018 Detail